DOI: https://doi.org/10.22263/2312-4156.2023.2.27
D.I. Haurylenka, T.Y. Haurylenka, E.V. Rodina
Nutritional disorders in chronic liver diseases. Part 2. Assessment of sarcopenia and correction of eating disorders
Republican Research Centre for Radiation Medicine and Human Ecology, Gomel, Republic of Belarus
Vestnik VGMU. 2023;22(2):27-34.
Abstract.
Introduction. The pathophysiology of abnormalities associated with insufficient intake of nutrients in chronic liver diseases emphasizes the importance of therapeutic interventions for malnutrition and sarcopenia, which are dynamic conditions and have the potential for regress if properly corrected.
Objectives. To review in brief publications highlighting the problem of assessing sarcopenia, the latest guidelines for the correction of malnutrition in chronic diffuse liver diseases.
Material and methods. The study and analysis of the English and Russian languages articles with a search depth of up to 30 years, contained in the PubMed, Cochrane Collaboration, UpToDate, eLIBRARY databases, were carried out. Key words and their combinations were: “body mass index”, “malnutrition”, “muscle wasting”, “nutrition risk”, “sarcopenia”, “nutrition status”, “complications of liver cirrhosis”.
Results. Recommendations are given concerning diet, calorie consumption and protein intake in patients with chronic liver diseases, primarily with liver cirrhosis. Recommendations for changing physical activity in case of malnutrition are discussed. Some mistakes in the correction of malnutrition in this group of patients are also analyzed.
Conclusions. The current recommendations for the management of malnutrition and its key manifestation, sarcopenia, are undoubtedly beneficial, which is confirmed by a number of studies in groups of patients with chronic liver diseases. Correction of nutritional status disorders in liver diseases should be one of the tasks of the practicing doctor, the implementation of which has the potential to change the poor prognosis.
Keywords: liver cirrhosis, malnutrition, sarcopenia, nutritional status.
References
1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019 Jan;70(1):172-93. doi: http://dx.doi.org/10.1016/j.jhep.2018.06.024
2. Dasarathy J, McCullough AJ, Dasarathy S. Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances. Alcohol Clin Exp Res. 2017 Aug;41(8):1419-31. doi: http://dx.doi.org/10.1111/acer.13425
3. Holeček M. Branched-chain amino acid supplementation in treatment of liver cirrhosis: Updated views on how to attenuate their harmful effects on cataplerosis and ammonia formation. Nutrition. 2017 Sep;41:80-5. doi: http://dx.doi.org/10.1016/j.nut.2017.04.003
4. Qiu J, Thapaliya S, Runkana A, Yang Y, Tsien C, Mohan ML, et al. Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB-mediated mechanism. Proc Natl Acad Sci U S A. 2013 Nov;110(45):18162-7. doi: http://dx.doi.org/10.1073/pnas.1317049110
5. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56. doi: http://dx.doi.org/10.1093/gerona/56.3.m146
6. Wang CW, Feng S, CovinskyKE, Hayssen H, Zhou LQ, Yeh BM, et al. A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study. Transplantation. 2016 Aug;100(8):1692-8. doi: http://dx.doi.org/10.1097/TP.0000000000001232
7. Nardelli S, Lattanzi B, Torrisi S, Greco F, Farcomeni A, Gioia S, et al. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement. Clin Gastroenterol Hepatol. 2017 Jun;15(6):934-6. doi: http://dx.doi.org/10.1016/j.cgh.2016.10.028
8. Córdoba J, López-Hellín J, Planas M, Sabín P, Sanpedro F, Castro F, et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol. 2004 Jul;41(1):38-43. doi: http://dx.doi.org/10.1016/j.jhep.2004.03.023
9. Vaisman N, Katzman H, Carmiel-Haggai M, Lusthaus M, Niv E. Breakfast improves cognitive function in cirrhotic patients with cognitive impairment. Am J Clin Nutr. 2010 Jul;92(1):137-40. doi: http://dx.doi.org/10.3945/ajcn.2010.29211
10. Merli M. Nutrition in cirrhosis: Dos and Don'ts. J Hepatol. 2020 Dec;73(6):1563-5. doi: http://dx.doi.org/10.1016/j.jhep.2020.07.019
11. Bischoff SC, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T, et al. ESPEN practical guideline: Clinical nutrition in liver disease. Clin Nutr. 2020 Dec;39(12):3533-62. doi: http://dx.doi.org/10.1016/j.clnu.2020.09.001
12. Montano-Loza AJ, Angulo P, Meza-Junco J, Prado CM, Sawyer MB, Beaumont C, et al. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis. J Cachexia Sarcopenia Muscle. 2016 May;7(2):126-35. doi: http://dx.doi.org/10.1002/jcsm.12039
13. Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, et al. HALT-C Trial Group. Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology. 2009 Aug;137(2):549-57. doi: http://dx.doi.org/10.1053/j.gastro.2009.05.007
14. Macías-Rodríguez RU, Ilarraza-Lomelí H, Ruiz-Margáin A, Ponce-de-León-Rosales S, Vargas-Vorácková F, García-Flores O, et al. Changes in Hepatic Venous Pressure Gradient Induced by Physical Exercise in Cirrhosis: Results of a Pilot Randomized Open Clinical Trial. Clin Transl Gastroenterol. 2016 Jul;7(7):e180. doi: http://dx.doi.org/10.1038/ctg.2016.38
15. Malinovskaya YO, Kokina KY, Moisyuk YH, Sumtsova OV. The impact of late liver transplant dysfunction on the physical activity of recipients. Transplantologia.2021;13(4):356-66. (In Russ.)
16. Sinclair M, Grossmann M, Hoermann R, Angus PW, Gow PJ. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial. J Hepatol. 2016 Nov;65(5):906-13. doi: http://dx.doi.org/10.1016/j.jhep.2016.06.007
17. Matsumoto R, Fukuoka H, Iguchi G, Nishizawa H, Bando H, Suda K, et al. Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency. Growth Horm IGF Res. 2014 Oct;24(5):174-9. doi: http://dx.doi.org/10.1016/j.ghir.2014.07.002
Information about authors:
D.I. Haurylenka – Candidate of Medical Sciences, functional diagnosis doctor, head of the department of functional diagnosis, Republican Research Center for Radiation Medicine and Human Ecology, https://orcid.org/0000-0001-7496-6164
e-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Dzmitry I. Haurylenka;
T.Y. Haurylenka – gastroenterologist, head of the reception department, Republican Research Centre for Radiation Medicine and Human Ecology;
E.V. Rodina – functional diagnosis doctor, Republican Research Centre for Radiation Medicine and Human Ecology.
